28 Approved Peptides with MW < 2000


TERLIPRESSIN Approved in 2022 (PDB entries)

DIFELIKEFALIN Approved in 2021 (PDB entries)

VOCLOSPORIN Approved in 2021 (PDB entries)

SETMELANOTIDE Approved in 2020 (PDB entries)

AFAMELANOTIDE Approved in 2019 (PDB entries)

BREMELANOTIDE Approved in 2019 (PDB entries)

L-GLUTAMINE Approved in 2017 (PDB entries)

ETELCALCETIDE Approved in 2017 (PDB entries)

PLECANATIDE Approved in 2017 (PDB entries)

ANGIOTENSIN II Approved in 2017 (PDB entries)

VASOPRESSIN (Re)approved in 2014 (PDB entries)

LINACLOTIDE Approved in 2012 (PDB entries)

TRIPTORELIN Approved in 2000 (PDB entries)

EPTIFIBATIDE Approved in 1998 (PDB entries)

NAFARELIN Approved in 1990 (PDB entries)

GOSERELIN Approved in 1989 (PDB entries)

OCTREOTIDE Approved in 1988 (PDB entries)

LEUPROLIDE Approved in 1985 (PDB entries)

CYCLOSPORINE Approved in 1983 (PDB entries)

GLUTATHIONE DISULFIDE Approved in 1981 (PDB entry 1YKC)

OXYTOCIN Approved in 1980 (PDB entries)

DESMOPRESSIN Approved in 1978 (PDB entries)

SINCALIDE Approved in 1976 (PDB entries)

PENTAGASTRIN DISCONTINUED (Approved in 1974) (PDB entries)

GRAMICIDIN Approved in 1968 (PDB entries)

TYROSINE DISCONTINUED (PDB entry 4QBT)

LYPRESSIN DISCONTINUED (PDB entries)

SARALASIN DISCONTINUED (PDB entries)